A pioneering scientific program to anticipate the risk of leukemia induced by previous anticancer treatments.

Project leader: Jean-Baptiste Micol

Clémence Nguyen-Vigouroux,
chercheuse

" Si vous êtes passionnée, foncez ! "

Dr Sophie Postel-Vinay,
femme de science, l’innovation thérapeutique à cœur

A pioneering scientific program to better understand the epigenetic biology of tumors and find new treatments.

Project leader: Sophie Postel-Vinay

 Dr. Jean-Baptiste Micol

Sylvain Ducroz

Sylvain Ducroz graduated from the Institut d'Etudes Politiques (formerly Sciences-Po) in Paris in 1998 and from the École nationale de santé publique (now the École des hautes études en santé publique, EHESP) in 2000.

Villejuif, le 23 février 2023

Publications

• Diagnostic accuracy of in vivo early tumor imaging from probe-based confocal laser endomicroscopy versus histologic examination in head and neck squamous cell carcinoma.
   Auteur(s) : Abbaci, M ; Casiraghi, O ; Vergez, S ; Maillard, A ; Lakhdar, AB ; De Leeuw, F & al    
   DOI : 10.1007/s00784-021-04156-4
•  Genomics to select treatment for patients with metastatic breast cancer.
   Auteur(s) : Andre, F ; Filleron, T ; Kamal, M ; Mosele, F ; Arnedos, M ; Dalenc, F & al    
   DOI : 10.1038/s41586-022-05068-3 

Villejuif, 17th february 2023